Artiva Net Interest Income from 2010 to 2026
| ARTV Stock | 4.06 0.04 1.00% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter 6.2 M | Current Value 6.5 M | Quarterly Volatility 2.4 M |
Check Artiva Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Artiva Biotherapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 6.5 M, Interest Income of 6.5 M or Depreciation And Amortization of 2.9 M, as well as many indicators such as Price To Sales Ratio of 925, Dividend Yield of 0.0 or PTB Ratio of 1.24. Artiva financial statements analysis is a perfect complement when working with Artiva Biotherapeutics Valuation or Volatility modules.
Artiva | Net Interest Income | Build AI portfolio with Artiva Stock |
The evolution of Net Interest Income for Artiva Biotherapeutics Common provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Artiva Biotherapeutics compares to historical norms and industry peers.
Latest Artiva Biotherapeutics' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Artiva Biotherapeutics Common over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Artiva Biotherapeutics' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Artiva Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Artiva Net Interest Income Regression Statistics
| Arithmetic Mean | 1,154,192 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 210.06 | |
| Mean Deviation | 1,884,389 | |
| Median | (197,000) | |
| Standard Deviation | 2,424,476 | |
| Sample Variance | 5.9T | |
| Range | 6.7M | |
| R-Value | 0.77 | |
| Mean Square Error | 2.5T | |
| R-Squared | 0.60 | |
| Significance | 0.0003 | |
| Slope | 370,531 | |
| Total Sum of Squares | 94T |
Artiva Net Interest Income History
About Artiva Biotherapeutics Financial Statements
Artiva Biotherapeutics investors use historical fundamental indicators, such as Artiva Biotherapeutics' Net Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Artiva Biotherapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 6.2 M | 6.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Artiva Stock Analysis
When running Artiva Biotherapeutics' price analysis, check to measure Artiva Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics is operating at the current time. Most of Artiva Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics' price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics to your portfolios can decrease your overall portfolio volatility.